Product Description
Cobaniran-C Tablets contain Cerebroprotein Hydrolysate 90 mg, a neuro-protective. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.
Indications
Recovery after stroke or head injury
Memory and cognitive decline
Dosage
As directed by the physician.
Side Effects
Dizziness, drowsiness, dry mouth or weight gain may occur. Avoid alcohol and driving if drowsy. Do not stop suddenly; use only as prescribed.
Storage Instructions
Store in a cool, dry place below 30°C, protected from light and moisture.
Keep out of the reach of children.
Availability
Cobaniran-C Tablets is available for PCD Pharma Franchise distribution and Third-Party Contract Manufacturing across India. Reach out to the manufacturer for pricing, MOQ and territory details.
Pharmaceutical Specifications
| Product Name | Cobaniran-C Tablets |
| Dosage Form | Tablet |
| Composition | Cerebroprotein Hydrolysate 90 mg |
| Strength | N/A |
| Packing | 10x1x10 Alu-Alu (Mono Carton) |
| MRP | On Request |
| Prescription | Rx Required |
| Manufactured by | Pharmakon Lifesciences, Karnal |
| Delivery Time | 15–25 working days |
| Certifications | ISO 9001:2015 · WHO-GMP · Verified Company |
Company Information
Pharmakon Lifesciences
Karnal-based pharma company offering PCD franchise and third-party manufacturing in neuro, derma, gynae, ortho, dental and paediatric ranges. Operating since 2018.
